Evidence of clinical efficacy of a first generation CD19 CAR T cell in B cell malignancies.

Shohdy, Kyrillus S; Pillai, Manon; Guest, Ryan; Rothwell, Dominic; Kirillova, Natalia; Chow, Shien; Gilham, David; Thistlethwaite, Fiona; Hawkins, Robert

Evidence of clinical efficacy of a first generation CD19 CAR T cell in B cell malignancies.

Shohdy, Kyrillus S; Pillai, Manon; Guest, Ryan; Rothwell, Dominic; Kirillova, Natalia; Chow, Shien; Gilham, David; Thistlethwaite, Fiona; Hawkins, Robert.

Afiliação

Shohdy KS; Division of Cancer Sciences The University of Manchester and The Christie NHS Foundation Trust Manchester UK.
Pillai M; Department of Clinical Oncology Cairo University Cairo Egypt.
Guest R; Division of Cancer Sciences The University of Manchester and The Christie NHS Foundation Trust Manchester UK.
Rothwell D; Division of Cancer Sciences The University of Manchester and The Christie NHS Foundation Trust Manchester UK.
Kirillova N; Cancer Research UK Manchester Institute Cancer Biomarker Centre The University of Manchester Manchester UK.
Chow S; Division of Cancer Sciences The University of Manchester and The Christie NHS Foundation Trust Manchester UK.
Gilham D; Division of Cancer Sciences The University of Manchester and The Christie NHS Foundation Trust Manchester UK.
Thistlethwaite F; Clinical and Experimental Immunotherapy Group Institute of Cancer Sciences, Manchester Academic Healthcare Science Centre Manchester UK.
Hawkins R; Division of Cancer Sciences The University of Manchester and The Christie NHS Foundation Trust Manchester UK.

EJHaem ; 4(3): 882-885, 2023 Aug.

Article em En | MEDLINE | ID: mdl-37601889

Palavras-chave

B cell malignancies; CART cell therapy; Phase I trial; firstgeneration

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: EJHaem Ano de publicação: 2023 Tipo de documento: Article